Rangeley Capital’s Anebulo Pharmaceuticals ANEB Stock Holding History

Rangeley Capital’s Portfolio ANEB Stock Details ANEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$50.5K	–	138
2025 Q4	$50.5K	Buy	50,000 +30,000	+150%	+$68.5K	0.04%	115
2025 Q3	$50K	Buy	+20,000	New	+$47.1K	0.04%	120

Rangeley Capital's ANEB Position: Q1 2026 in Review

Rangeley Capital sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2026, closing a stake of 50,000 shares — an estimated $50.5K sold.

Rangeley Capital first reported a position in ANEB in Q3 2025 and held it in 2 quarters. The position peaked at $50.5K in Q4 2025. 0 funds tracked by Wall St. Rank hold ANEB as of Q1 2026.

Rangeley Capital reported no remaining Anebulo Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Rangeley Capital sold 50,000 Anebulo Pharmaceuticals shares in Q1 2026, an estimated $50.5K.
Rangeley Capital first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Rangeley Capital's Anebulo Pharmaceuticals position peaked at $50.5K in Q4 2025.
0 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.